Atlas Lithium Corp (ATLX) stock intrinsic value fair value estimate & owner earnings analysis

Atlas Lithium is a pre-revenue mineral exploration and development company. Its main asset is the Minas Gerais Lithium Project in Brazil (85 mineral rights, about 468 square kilometers), centered on the Neves Project. In 2025 it received a modular dense media separation plant designed to produce about 150,000 tons per year of lithium concentrate. It also owns about 28% of Atlas Critical Minerals (Nasdaq: ATCX), which is consolidated in its accounts. The business does not currently earn money. Reported revenue was about $121 thousand in 2025 against a net loss of about $28 million. On our owner-earnings measure (operating cash flow, less working-capital swings, less stock compensation, less capital spending) the company lost roughly $2.01 per share in 2025, $4.62 in 2024, $3.21 in 2023 and $1.43 in 2022. Stock compensation is a large part of that ($9.3 million in 2025, $25.3 million in 2024) and we treat it as a real cost. Because revenue is negligible, we treated all capital spending as maintenance rather than splitting off growth spending. Earlier years are not stored because the share counts needed to express them per share could not be established. The one contract on record is an Offtake and Sales Agreement with Mitsui & Co., Ltd. Mitsui agreed to buy a spot quantity of 15,000 dry metric tons and, subject to conditions not yet satisfied, at least 60,000 dry metric tons per year for five years. That is a real signal of demand, but it is conditional, and the filing gives no price, production cost or margin we could use to turn it into earnings. The company also states that it lacks established mineral reserves and that revenue from operations is uncertain. All three cases are therefore valued at $0 per share. Bear: production never reaches profitable scale and the company keeps funding losses by issuing shares. Base and bull: nothing we can name and evidence today produces positive owner earnings, so no value is credited. We did not credit the Mitsui volumes, planned production or the ATCX stake, because none has yet produced cash we can measure. This is a statement that the value cannot be supported from the filings, not a claim that the shares can never be worth something: if the plant ships concentrate at a profit, the value would be well above zero. Financial position: at December 31, 2025 the company held about $35.9 million of cash against roughly $10.0 million of convertible debt, now current. Management states cash is sufficient for at least twelve months. Cash is not added to the valuation because it is being consumed by operating losses and capital spending. Continued equity issuance dilutes existing holders; diluted shares rose from about 9.3 million in 2023 to 18.2 million in 2025. What would have to be true for this to be wrong: commercial shipments under the Mitsui agreement at prices well above cash costs, which would need to appear in reported results before we credit them.